← Stocks · NDRA record
Signal record & history · Trifecta Signals
ENDRA has been flagged by the Trifecta screener 1 time since 2024. 1 signal confirmed; the median confirmed signal is down 78.1% since its Early Signal.
Price refreshes every trading day after the close.
Full interactive chart ↗ · partner link
Daily closes · through the most recent close
Price history from Jan 2018 · Signal tracking began Jan 2022
Headline statistics: confirmed signals only, measured from the confirmation price.
First signal Aug 2024 · Latest Aug 2024 · Confirmed 1 of 1 Early · Latest close in the chart data: Wed, Nov 4, 2026
Groups are mutually exclusive — every confirmed signal sits in exactly one.
Since August 2024, ENDRA has had one Early signal, one confirmed. Its one decided signal did not reach +10% within 90 days, and it did not finish ahead of the S&P 500 since confirmation.
Every Early signal in the record, newest first.
Members see every signal below, and the group mix above.
Membership unlocks the complete signal timeline for NDRA and every other stock in the record — group tags, caution flags, and the full screener.
Already a member? Sign in and this page unlocks.
ENDRA Life Sciences is classified in the Healthcare sector, Medical Devices industry. With a market value of about $7.3 million, the company falls in the small-cap group.
ENDRA Life Sciences’ standout Trifecta run followed a September 2024 confirmation, falling about 55% over the next 90 days. On classification, its latest signal was rated Low Quality, and it sat in the small-cap group when that signal fired.
The stock closed Wednesday, November 4 at $4.94, up 1.6% on the day. Over the past week, the shares have traded in a narrow range between about $4.75 and $4.94.
